14-day Premium Trial Subscription Try For FreeTry Free
$1.20
+0.0100 (+0.84%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.15 $1.58 Friday, 3rd May 2024 APTO stock ended at $1.20. This is 0.84% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.36% from a day low at $1.19 to a day high of $1.23.
90 days $1.15 $2.20
52 weeks $0.360 $6.60

Historical Aptose Biosciences prices

Date Open High Low Close Volume
Mar 29, 2023 $0.612 $0.640 $0.600 $0.627 54 567
Mar 28, 2023 $0.647 $0.675 $0.606 $0.631 101 363
Mar 27, 2023 $0.644 $0.660 $0.620 $0.647 193 561
Mar 24, 2023 $0.600 $0.663 $0.549 $0.644 445 483
Mar 23, 2023 $0.580 $0.590 $0.540 $0.570 195 493
Mar 22, 2023 $0.588 $0.600 $0.580 $0.585 40 500
Mar 21, 2023 $0.580 $0.610 $0.580 $0.590 101 681
Mar 20, 2023 $0.520 $0.599 $0.520 $0.587 360 449
Mar 17, 2023 $0.580 $0.580 $0.523 $0.532 134 297
Mar 16, 2023 $0.560 $0.586 $0.560 $0.564 179 888
Mar 15, 2023 $0.582 $0.590 $0.560 $0.580 46 911
Mar 14, 2023 $0.567 $0.582 $0.540 $0.582 130 630
Mar 13, 2023 $0.520 $0.550 $0.520 $0.539 85 493
Mar 10, 2023 $0.550 $0.560 $0.524 $0.530 132 681
Mar 09, 2023 $0.570 $0.580 $0.550 $0.559 141 315
Mar 08, 2023 $0.570 $0.580 $0.550 $0.562 109 919
Mar 07, 2023 $0.580 $0.580 $0.560 $0.560 78 384
Mar 06, 2023 $0.580 $0.590 $0.560 $0.564 155 756
Mar 03, 2023 $0.580 $0.620 $0.575 $0.580 70 319
Mar 02, 2023 $0.580 $0.607 $0.570 $0.588 61 178
Mar 01, 2023 $0.620 $0.620 $0.570 $0.586 56 881
Feb 28, 2023 $0.624 $0.624 $0.570 $0.582 183 315
Feb 27, 2023 $0.620 $0.660 $0.590 $0.617 212 042
Feb 24, 2023 $0.648 $0.680 $0.625 $0.640 39 932
Feb 23, 2023 $0.666 $0.666 $0.630 $0.660 33 066
Click to get the best stock tips daily for free!

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT